Avantor, Inc. ($AVTR) Stock Forecast: Down 6.0% Today

What is Avantor, Inc.?

Avantor (AVTR) is a life science tools company that reported in-line earnings for its first quarter, with robust growth in its Bioscience Production segment despite macroeconomic pressures.

Why is Avantor, Inc. going down?

AVTR stock is down 6.0% on Apr 28, 2025 17:20

• AVTR stock experienced a bearish movement despite reporting in-line earnings for Q1, with revenues slightly down year-over-year. This could have contributed to the negative market sentiment.
• Analysts cutting their forecasts after the Q1 results may have added to the bearish pressure on AVTR stock, as it indicates a lack of confidence in the company's future performance.
• The news of Avantor's CEO stepping down and the company planning a leadership change and strategy shift might have created uncertainty among investors, leading to the bearish market movement.
• Overall, the combination of missed revenue estimates, analyst downgrades, and leadership changes likely fueled the bearish sentiment surrounding AVTR stock.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y

AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.

https://www.zacks.com/stock/news/2457026/avantor-stock-declines-despite-q1-earnings-in-line-revenues-down-yy

Avantor Analysts Cut Their Forecasts After Q1 Results - Avantor ( NYSE:AVTR )

Avantor Inc AVTR reported in-line earnings for its first quarter on Friday. The company posted adjusted EPS of 23 cents in line with consensus. The life science tools company reported sales of $1.58 billion, missing the consensus of $1.61 billion.

https://www.benzinga.com/25/04/45038680/avantor-analysts-cut-their-forecasts-after-q1-results

This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday - Adecoagro ( NYSE:AGRO ) , Avantor ( NYSE:AVTR )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

https://www.benzinga.com/25/04/45037847/this-eli-lilly-analyst-turns-bearish-here-are-top-4-downgrades-for-monday

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift - Avantor ( NYSE:AVTR )

Avantor Q1 sales fell 6% to $1.58 billion, missing estimates by $30 million. CEO Stubblefield to step down as cost savings target rises to $400 million. Today's manic market swings are creating the perfect setup for Matt's next volatility trade. Get his next trade alert for free, right here.

https://www.benzinga.com/general/health-care/25/04/45014623/avantor-sees-steady-earnings-plans-leadership-change-and-strategy-shift

Avantor, Inc. ( AVTR ) Q1 Earnings Meet Estimates

Avantor (AVTR) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2455569/avantor-inc-avtr-q1-earnings-meet-estimates

Trending Today

Reddit Inc ($RDDT) Stock Forecast: Down 5.2% Today

Franklin Resources Inc. ($BEN) Stock Forecast: Up 6.4% Today

Motorola Solutions Inc. ($MSI) Stock Forecast: Down 8.2% Today

Novo Nordisk A/S ($NVO) Stock Forecast: Up 5.1% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 5.2% Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.1% Today

Becton Dickinson and Company ($BDX) Stock Forecast: Down 5.0% Today

Sui ($SUI) Crypto Forecast: Down 5.5% Today

Roblox Corp ($RBLX) Stock Forecast: Up 6.9% Today

Xerox Corporation ($XRX) Stock Forecast: Up 10.7% Today

Avantor, Inc. Price History

25.03.2025 - AVTR Stock was down 16.0%

• AVTR's Q1 earnings meeting estimates may have been perceived as lackluster by investors, leading to a bearish movement in the stock.
• The slight revenue surprise of 1.72% might not have been enough to offset any concerns about the company's future growth prospects.
• Investors may be looking for stronger signals of growth and performance from AVTR to regain confidence in the stock, contributing to the bearish market movement today.

25.03.2025 - AVTR Stock was down 20.4%

• Q1 sales for Avantor dropped by 6%, falling $30 million below expectations, which likely influenced the bearish trend.
• The resignation of CEO Stubblefield, a change in company strategy, and an increased cost savings target of $400 million may have introduced uncertainty and negative sentiment among investors.
• Despite meeting earnings predictions, a modest revenue surprise of 1.72% may not have been enough to alleviate concerns about the sales decrease and leadership adjustments, contributing to the market's bearish direction.
• General market volatility likely heightened the stock's decline, in line with observations on unpredictable market fluctuations leading to increased volatility trading.

25.09.2024 - AVTR Stock was down 5.5%

• The strong bearish movement in AVTR stock could be attributed to profit-taking by investors after the stock beat Q3 earnings estimates. This could indicate that some investors are selling off their positions to lock in profits.
• The divestiture deal with Audax to sell its clinical services business may have also contributed to the bearish movement, as investors may be uncertain about the impact of this strategic decision on the company's future growth prospects.
• Despite beating earnings estimates, the slight revenue surprise may have raised concerns among investors about the company's ability to sustain its growth momentum in the coming quarters, leading to a bearish sentiment in the market.
• Overall, the combination of profit-taking post-earnings beat and uncertainty surrounding the divestiture deal could have driven the bearish movement in AVTR stock today.

15.00.2025 - AVTR Stock was up 1.7%

• Avantor, Inc. is a leading global provider of products, services, and solutions for professionals in the life sciences and advanced technologies industries. The company aims to enable innovative research and healthcare solutions.
• CareDx (CDNA) saw a rise in its shares, but recent trends in earnings estimate revisions may not lead to further price increases in the short term. This shift in investor focus could be boosting the stock price of Avantor, Inc.
• A comparison between Pediatrix Medical Group (MD) and Avantor, Inc. is being made to gauge which stock is more appealing to value investors. This comparison may have underscored the growth potential and value proposition of Avantor, Inc., contributing to its current bullish movement.

28.03.2025 - AVTR Stock was down 5.3%

• The stock of Avantor witnessed a downward movement during the latest trading session.
• Analysts revised their projections for Avantor following the first-quarter results, hinting at potential apprehensions about its future performance.
• Factors such as the company's failure to meet sales expectations, the CEO's resignation, and a strategic shift in direction could have influenced the prevailing negative market sentiment.
• The overall market outlook for Avantor appears to be influenced by internal organizational changes and external market conditions, leading to a bearish trajectory in the stock's value.

28.03.2025 - AVTR Stock was down 6.0%

• AVTR stock experienced a bearish movement despite reporting in-line earnings for Q1, with revenues slightly down year-over-year. This could have contributed to the negative market sentiment.
• Analysts cutting their forecasts after the Q1 results may have added to the bearish pressure on AVTR stock, as it indicates a lack of confidence in the company's future performance.
• The news of Avantor's CEO stepping down and the company planning a leadership change and strategy shift might have created uncertainty among investors, leading to the bearish market movement.
• Overall, the combination of missed revenue estimates, analyst downgrades, and leadership changes likely fueled the bearish sentiment surrounding AVTR stock.

24.06.2024 - AVTR Stock was up 5.4%

• Unusual options activity: Significant funds taking a bullish position in AVTR could indicate insider confidence or strategic positioning for potential positive developments.
• Analysts estimating a decline in earnings: Despite the negative earnings outlook, the bullish movement suggests that investors may be focusing on other positive aspects of the company, such as potential growth opportunities or market trends.
• The combination of these factors could have contributed to the bullish movement in AVTR, showcasing a divergence between short-term earnings expectations and long-term investor sentiment.

26.06.2024 - AVTR Stock was up 13.9%

• Avantor Inc. reported Q2 earnings with a GAAP EPS of $0.14 and revenue of $1.70 billion, surpassing expectations, which likely contributed to the bullish movement.
• The company's improvements in key financial metrics, such as increased bioprocessing revenue and cost transformation initiatives, led to margin expansion and strong free cash flow conversion.
• Unusual bullish options activity in Avantor also caught the attention of investors, reflecting positive sentiment towards the stock.
• Despite analysts estimating a decline in earnings, the actual results and the company's reaffirmed guidance for fiscal year 2024 appear to have boosted investor confidence, driving the bullish market movement.

26.06.2024 - AVTR Stock was up 11.7%

• Earnings per share of 25 cents and revenue of $1.70 billion were reported by Avantor (AVTR), surpassing analyst estimates and slightly better than expected.
• The company's solid performance in the second quarter, with sequential improvements in key financial metrics, drove a bullish movement in the stock.
• The positive earnings report and reaffirmation of fiscal year 2024 guidance by Avantor's management likely instilled confidence in investors, leading to a surge in the stock price.
• Unusual options activity indicating a bullish position taken by investors further contributed to the positive sentiment surrounding Avantor, reinforcing the bullish market movement.

30.06.2024 - AVTR Stock was up 5.1%

• AVTR surpassed market expectations in the second quarter, reporting adjusted earnings of 25 cents per share. This exceeded forecasts.
• Despite revenue decline and a contraction in operating margins, the market responded positively to AVTR's earnings performance.
• AVTR's addition to the S&P MidCap 400 index, along with the general positive outlook on large-cap stocks, influenced the rise in AVTR's share price.
• Analysts raised their forecasts, and positive discussions surrounding AVTR's earnings likely boosted investor confidence and contributed to the stock's upward momentum.

07.07.2024 - AVTR Stock was down 5.0%

• The bearish movement in AVTR stock today could be attributed to the insider sale of 10,100 shares by EVP, AMEA Christophe Couturier. Insider selling is often perceived negatively by investors as it may indicate a lack of confidence in the company's future prospects.
• Investors might interpret this insider sale as a signal that someone within the company believes that the stock is overvalued or that there could be challenges ahead.
• This news could have triggered a sell-off among investors, leading to the bearish movement in AVTR stock as market participants reacted to the insider selling activity.

07.01.2025 - AVTR Stock was down 5.7%

• Despite surpassing adjusted EPS estimates, Q4 net sales for Avantor declined by 2% YoY, falling short of expectations, potentially contributing to the bearish market response.
• The forecast of 1%-3% organic revenue growth for 2025 may have underwhelmed investors seeking more robust growth forecasts.
• The combination of the mixed Q4 earnings report and the absence of a clear beat in earnings expectations likely created investor uncertainty, driving the bearish market trend for Avantor today.